07:00 , Jun 11, 2012 |  BC Week In Review  |  Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica computational chemistry/biology news

The U.K.'s Technology Strategy Board granted the companies £1 million ($1.5 million) to develop a highly-scalable discovery platform to identify diverse small molecules against therapeutic targets using Isogenica's libraries of binding peptides. The companies will...
07:00 , Jul 4, 2011 |  BC Week In Review  |  Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica deal

The companies partnered to develop a therapeutic discovery platform that will identify small molecules against therapeutic targets. The companies will use Cresset's field-based computational chemistry and Isogenica's CIS display technology in the new platform. Details...